Showing results (91-100 of 161) with videos related to

Sort By:
Pageof 17
Urologic Oncology|February 19, 2020
Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging resultJuan Morote, Anna Celma, Fernando Diaz, et al.
Urology|March 27, 2007
Prevalence of osteoporosis during long-term androgen deprivation therapy in patients with prostate cancerJuan Morote, Jacques Planas Morin, Anna Orsola, et al.
European Urology Open Science|July 13, 2023
Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate CancerJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
World Journal of Urology|September 12, 2019
How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsiesÁngel Borque-Fernando, Luis Mariano Esteban, Ana Celma, et al.
Frontiers in Oncology|August 28, 2024
Association of the rs1042522 SNP with prostate cancer risk: a study of cancer tissues, primary tumor cultures, and serum samples from a Spanish Caucasian populationEmily Toscano-Guerra, Valentina Maggio, Javier García, et al.
Clinical Genitourinary Cancer|October 26, 2024
Concordance Between the Expert Reading of Biparametric-MRI and the Nonexpert Multiparametric-MRI for the Detection of Clinically Significant Prostate Cancer: Clinical ImplicationsNahuel Paesano, María José Gutiérrez Vallecillo, Violeta Catalá, et al.
Cancers|April 10, 2020
Aurora Borealis (Bora), Which Promotes Plk1 Activation by Aurora A, Has an Oncogenic Role in Ovarian CancerAlfonso Parrilla, Marta Barber, Blanca Majem, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Alternating Cystoscopy with Bladder EpiCheck® in the Surveillance of Low-Grade Intermediate-Risk NMIBC: A Cost Comparison ModelYair Lotan, Georgios Gakis, Matteo Manfredi, et al.
Cancers|June 10, 2022
Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRIMiriam Campistol, Juan Morote, Marina Triquell, et al.
Cancer Letters|March 30, 2019
A novel DNA-binding motif in prostate tumor overexpressed-1 (PTOV1) required for the expression of ALDH1A1 and CCNG2 in cancer cellsValentina Maggio, Verónica Cánovas, Alex J Félix, et al.
Pageof 17